# The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy

Study · id `cardio:ct-nct01676116` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01676116](<https://clinicaltrials.gov/study/NCT01676116>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01676116

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 438 participants.

## Technical summary

Registry record NCT01676116. Randomized; no masking; primary purpose treatment. Start 2012-08-29 (actual); primary completion 2014-03-11 (actual). Results posted on 2018-07-09.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 438 participants (enrolled count; ClinicalTrials.gov record NCT01676116, source copy `cardio:ctgov-nct01676116-2019-01-03`, retrieved 2026-10-26)
- Started: 2012-08-29 (actual) (ClinicalTrials.gov record NCT01676116, source copy `cardio:ctgov-nct01676116-2019-01-03`, retrieved 2026-10-26)
- Primary completion: 2014-03-11 (actual) (ClinicalTrials.gov record NCT01676116, source copy `cardio:ctgov-nct01676116-2019-01-03`, retrieved 2026-10-26)
- Completion: 2014-03-11 (actual) (ClinicalTrials.gov record NCT01676116, source copy `cardio:ctgov-nct01676116-2019-01-03`, retrieved 2026-10-26)
- Results first posted: 2018-07-09 (ClinicalTrials.gov record NCT01676116, source copy `cardio:ctgov-nct01676116-2019-01-03`, retrieved 2026-10-26)
- Countries: United States; Australia; France; Hungary; Slovakia (ClinicalTrials.gov record NCT01676116, source copy `cardio:ctgov-nct01676116-2019-01-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01676116-2019-01-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy
- Acronym: DUAL™ III
- Condition: Diabetes
- Condition: Diabetes Mellitus, Type 2
- Intervention (Drug): insulin degludec/liraglutide
- Intervention (Drug): liraglutide
- Intervention (Drug): exenatide
- Lead sponsor: Novo Nordisk A/S
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Novo Nordisk (`cardio:novo-nordisk`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: EFFICACY AND SAFETY OF IDEGLIRA IN OLDER PATIENTS WITH TYPE 2 DIABETES (`cardio:pubmed-30383495`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 1a73e75b14ce494fb96cc7796cd7997c17ed9677ffcc4d8998aca1806f2044f3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
